507 related articles for article (PubMed ID: 16765487)
1. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
3. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.
Morgan D
Neurochem Int; 2006 Jul; 49(2):190-4. PubMed ID: 16740342
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta immunotherapies in mice and men.
Brendza RP; Holtzman DM
Alzheimer Dis Assoc Disord; 2006; 20(2):118-23. PubMed ID: 16772748
[TBL] [Abstract][Full Text] [Related]
6. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
Foster JK; Verdile G; Bates KA; Martins RN
Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
Schenk D
Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
[No Abstract] [Full Text] [Related]
8. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
9. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
Morgan D; Gitter BD
Neurobiol Aging; 2004; 25(5):605-8. PubMed ID: 15172737
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated immunotherapy for Alzheimer's disease.
Solomon B
Curr Opin Investig Drugs; 2007 Jul; 8(7):519-24. PubMed ID: 17659471
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.
Chauhan NB; Siegel GJ
J Neurosci Res; 2003 Oct; 74(1):142-7. PubMed ID: 13130516
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go?
von Bernhardi R
J Alzheimers Dis; 2010; 19(2):405-21. PubMed ID: 20110590
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools.
Lichtlen P; Mohajeri MH
J Neurochem; 2008 Feb; 104(4):859-74. PubMed ID: 17986215
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular delivery of a single chain antibody gene reduces brain Abeta burden in a mouse model of Alzheimer's disease.
Wang YJ; Pollard A; Zhong JH; Dong XY; Wu XB; Zhou HD; Zhou XF
Neurobiol Aging; 2009 Mar; 30(3):364-76. PubMed ID: 17686552
[TBL] [Abstract][Full Text] [Related]
15. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
Hara H; Inoue M; Adachi K; Yonemitsu Y; Hasegawa M; Nabeshima T; Tabira T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
[TBL] [Abstract][Full Text] [Related]
16. Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis.
Lee EB; Leng LZ; Lee VM; Trojanowski JQ
FEBS Lett; 2005 May; 579(12):2564-8. PubMed ID: 15862291
[TBL] [Abstract][Full Text] [Related]
17. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
18. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
[TBL] [Abstract][Full Text] [Related]
19. Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
Okura Y; Miyakoshi A; Kohyama K; Park IK; Staufenbiel M; Matsumoto Y
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9619-24. PubMed ID: 16769900
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
